Los Angeles Capital Management LLC G1 Therapeutics, Inc. Transaction History

Los Angeles Capital Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	BUY	$2.2 - $4.98 $46,169 - $104,510	20,986 New	20,986 $47,000
Q4 2021 Feb 03, 2022	SELL	$10.16 - $16.17 $116,443 - $185,324	-11,461 Closed	0 $0
Q2 2021 Aug 05, 2021	SELL	$19.57 - $26.32 $676,828 - $910,277	-34,585 Reduced 75.11%	11,461 $251,000
Q1 2021 May 05, 2021	SELL	$17.58 - $32.59 $1.27 Million - $2.36 Million	-72,265 Reduced 61.08%	46,046 $1.11 Million
Q4 2020 Feb 04, 2021	SELL	$10.99 - $20.4 $234,526 - $435,335	-21,340 Reduced 15.28%	118,311 $2.13 Million
Q3 2020 Nov 02, 2020	BUY	$11.55 - $23.75 $211,261 - $434,411	18,291 Added 15.07%	139,651 $1.61 Million
Q2 2020 Aug 05, 2020	BUY	$9.57 - $24.37 $575,817 - $1.47 Million	60,169 Added 98.33%	121,360 $2.94 Million
Q1 2020 May 04, 2020	BUY	$9.07 - $26.32 $378,717 - $1.1 Million	41,755 Added 214.83%	61,191 $674,000
Q4 2019 Feb 07, 2020	BUY	$20.54 - $31.0 $399,215 - $602,516	19,436 New	19,436 $514,000

3.55M

11.7K

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Los Angeles Capital Management LLC with notifications on news.